Recent genome-wide association studies of pediatric inflammatory bowel disease have implicated the 17q12 loci, which contains the eosinophil-specific chemokine gene CCL11, with early-onset inflammatory bowel disease susceptibility. In the current study, we employed a murine model of experimental colitis to define the molecular pathways that regulate CCL11 expression in the chronic intestinal inflammation and pathophysiology of experimental colitis. Bone marrow chimera experiments showed that hematopoietic cell-derived CCL11 is sufficient for CCL11-mediated colonic eosinophilic inflammation. We show that dextran sodium sulfate (DSS) treatment promotes the recruitment of F4/80 + CD11b + CCR2 + Ly6C high inflammatory monocytes into the colon. F4/80 + CD11b + CCR2 + Ly6C high monocytes express CCL11, and their recruitment positively correlated with colonic eosinophilic inflammation. Phenotypic analysis of purified Ly6C high intestinal inflammatory macrophages revealed that these cells express both M1-and M2-associated genes, including Il6, Ccl4, Cxcl2, Arg1, Chi3l3, Ccl11, and Il10, respectively. Attenuation of DSS-induced F4/80 + CD11b + CCR2 + Ly6C high monocyte recruitment to the colon in CCR2 2/2 mice was associated with decreased colonic CCL11 expression, eosinophilic inflammation, and DSS-induced histopathology. These studies identify a mechanism for DSS-induced colonic eosinophilia mediated by Ly6C high CCR2 + inflammatory monocyte/macrophage-derived CCL11. The Journal of Immunology, 2011, 186: 000-000.
T he inflammatory bowel diseases (IBD)
Crohn's disease (CD) and ulcerative colitis (UC) are chronic relapsing gastrointestinal (GI) inflammatory diseases that cause substantial morbidity and decreased quality of life. Over 30 years ago, Rutgeerts and colleagues (1) observed that apthous ulcers containing an eosinophilc infiltrate and blunted villi were the earliest endoscopic signs of recurrence in the neoterminal ileum and anastomosis following surgical resection for CD. Eosinophils usually represent only a small percentage of the infiltrating leukocytes (2, 3) , but their level has been proposed to be a negative prognostic indicator (3, 4) . Notably, elevated fecal concentrations of the eosinophil-derived granule proteins ECP and EPO were associated with clinical relapse within 3 mo in CD (5) . Since these initial studies, there have been a number of studies suggesting eosinophil involvement in IBD. Elevated levels of eosinophils have been observed in colonic biopsy samples from UC patients, and increased numbers of this cell and eosinophil-derived granule proteins MBP, ECP, EPO, and EDN have been shown to correlate with morphological changes to the GI tract, disease severity, and GI dysfunction (5) (6) (7) (8) (9) (10) . Increased numbers of tissue eosinophils with ultrastructural evidence of activation has also been observed in patients with CD (11) (12) (13) . Consistent with this clinical observation, dextran sodium sulfate (DSS)-induced histopathology is attenuated in mice deficient in eosinophils (14) (15) (16) .
Genome-wide association studies of pediatric and adult IBD have revealed a number of IBD susceptibility genes associated with innate (CARD15, ATG16L1, and IRGM) and adaptive (IL23R, IL10, IL12B, and STAT3) immunity. Furthermore, a recent investigation identified a significant association between the C-C motif chemokine cluster on 17q12 loci, which contains the eosinophil-specific chemokine gene CCL11, and early-onset CD (17) . CCL11 is a member of the CC chemokine family (18) and is a relatively potent and specific eosinophil chemoattractant (19) (20) (21) . CCL11 is constitutively expressed in a variety of tissues that contain eosinophils such as the GI tract and thymus (22) (23) (24) (25) . Genetic deletion of CCL11 abrogates eosinophil recruitment during eosinophil-associated pulmonary and GI disease, suggesting an important role for CCL11 in eosinophil trafficking during disease (26) (27) (28) (29) . Consistent with this, clinical investigations by us and others demonstrate increased CCL11 mRNA levels in sputum and intestinal biopsy samples from asthmatic and eosinophilic GI disorder patients. Importantly, the levels of CCL11 positively correlated with tissue eosinophilia (14, 25, 26) .
Although a link between CCL11 and eosinophils in IBD has been established, the cellular source of CCL11 and molecular regulation of CCL11 expression in experimental colitis is not yet delineated. In the current study, we employed a model of DSS-induced colitis, which features a pronounced CCL11-dependent eosinophilic inflammation, to decipher the molecular regulation of CCL11 in experimental colitis. Performing bone marrow (BM) chimera experiments, we show that hematopoietic cell-derived CCL11 is required for DSS-induced colonic eosinophilic inflammation. 
Ly6C
high monocyte recruitment was associated with decreased intestinal CCL11 expression, colonic eosinophilic inflammation, and DSS-induced histopathology. These studies demonstrate that inflammatory monocyte/ MF-derived CCL11 drives colonic eosinophilic inflammation in experimental colitis.
Materials and Methods

Mice
Male and female, 6-8-wk-old strain-, age-, and weight-matched CCR2
2/2 (C57BL/6) (The Jackson Laboratory, Bar Harbor, ME), C57BL/6, BALB/c, CCL11
2/2 (BALB/c) (30), CX 3 CR1 GFP/+ (The Jackson Laboratory), and Nzeg-enhanced GFP (eGFP) (31) mice were used. All mice were housed under specific pathogen-free conditions and treated according to institutional guidelines.
DSS-induced colonic injury and histopathologic examination
DSS (ICN Chemicals; 40-45 kDa) was administered in the drinking water as a 2.5-5% (w/v) solution for up to 8 d. Disease monitoring and histopathologic changes in the colon were scored as previously described (14) .
Immunofluorescence microscopy
Immunofluorescence analysis was performed as previously described (14, 32) . In brief, frozen sections were fixed in 10% acetone for 10 min, rinsed in PBS, blocked with 3% goat serum/PBS for 2 h at room temperature, and incubated with primary Ab rat anti-mouse F4/80 (5 mg/ml; eBioscience, San Diego, CA) in 3% normal goat serum/PBS. Sections were incubated with isotype control alone in place of primary Ab as a negative control. After an overnight incubation at 4˚C, sections were washed with 0.1% BSA and 0.05% Tween/PBS and incubated with goat anti-rat Alexa Fluor 594 (Invitrogen, Carlsbad, CA) for 2 h at room temperature. Slides were washed in PBS and counterstained with DAPI/Supermount G solution (Southern Biotechnology Associates, Birmingham, AL). Images were captured using a Zeiss microscope fitted with Zeiss UPlanApo lenses (310, 320, and 340 magnification) and an AxioCam MRc camera and analyzed with Axioviewer version 3.1 image analysis software (Carl Zeiss, Jena, Germany). Postacquisition processing (brightness, opacity, contrast, and color balance) was applied to the entire image and accurately reflects that of the original.
ELISA
CCL11, IL-6, and TNF-a levels were measured in the supernatants using the ELISA Duo-Set kit according to the manufacturer's instructions (R&D Systems, Minneapolis, MN).
MBP staining
Eosinophil levels were quantified by anti-MBP immunohistochemistry as previously described (33) .
Punch biopsies
Colons were excised, flushed with PBS with gentamicin (20 mg/ml), and opened along a longitudinal axis. Thereafter, 3-mm 2 punch biopsies were excised and incubated for 24 h in a 24-well plate with RPMI 1640 supplemented with 10% FCS and antibiotics. Supernatants were collected and kept at 220˚C until assessed for cytokines/chemokines by ELISA.
Real-time PCR analysis
Mouse Hprt, Ccl11, Retnla, Chi3l3, Arg1, Trem1, Ccl22, Ccl17, Cxcl2, Ccl4, Cxcl10, Pdgfb, Il1b, Tnf, Il6, Ccl3, and Il10 mRNA were quantified by real-time PCR as previously described (34) . In brief, the RNA samples (1 mg) were subjected to reverse transcription analysis using SuperScript II reverse transcriptase (Invitrogen) according to the manufacturer's instructions and quantified using the iQ5 multicolor real-time PCR detection system (Bio-Rad, Hercules, CA) with iQ5 software V2.0 and LightCycler FastStart DNA Master SYBR Green I (Bio-Rad). Primer sets are listed in Supplemental Table I . Gene expression was determined as relative expression on a linear curve based on a gel-extracted standard and was normalized to Hprt amplified from the same cDNA mix. Results were expressed as gene of interest/Hprt ratio.
Intestinal MF purification
MF populations from the colons of CX 3 CR1 eGFP/+ (C57BL/6) were isolated as previously described (14) . In brief, the colon segment of the GI tract was removed and flushed with 20 ml Ca 2+ -and Mg 2+ -free HBSS. The colon was cut longitudinally, placed in Ca 2+ -and Mg 2+ -free HBSS containing 10% FBS/5 mM EDTA/25 mM HEPES, and shaken vigorously at 37˚C for 30 min. The tissue was cut into 1-cm segments and incubated in digestion buffer containing 2.4 mg/ml collagenase A (Roche Diagnostics, Indianapolis, IN) and 0.2 mg/ml DNase I (Roche Diagnostics) in RPMI 1640 for 45 min on a shaker at 37˚C. Following incubation, the cell aggregates were dissociated by filtering thorough a 19-gauge needle and 70-mm filter and centrifuged at 1200 rpm for 20 min at 4˚C. The supernatant was decanted and the cell pellet resuspended in 1% FBS/5 mM EDTA/PBS, and cells were incubated for 30 min with biotinylated rat antimouse CD11b (1 mg/1 3 10 6 cells; BD Pharmingen, San Jose, CA) at 4˚C. Cells were subsequently incubated with anti-biotin microbeads (Miltenyi Biotec, Auburn, CA) for 15 min at 10˚C and purified by LS MACS column by positive selection as described by the manufacturer. In brief, 1 ml of cell suspension was added to the LS column, and the column was washed three times with 3 ml of 5 mM EDTA/1% FBS/PBS. CD11b + cells were removed from the column using a plunger. After washing, CD11b + -selected cells were labeled with rat anti-mouse Ly6C-Alexa 647 (AbD Serotec, Raleigh, NC) and immediately sorted using an FACSAria cell sorter (BD Biosciences, San Jose, CA) for CX 3 CR1-eGFP and Ly6C. Purity of CX 3 CR1 low Ly6C high cells was .95% as assessed by flow cytometry. RNA was isolated using the Qiagen RNeasy micro kit for cDNA synthesis (Qiagen) and RT-PCR analysis was performed as described above.
Monocyte enrichment
Peripheral blood was collected in K 2 EDTA tubes, and RBCs were lysed using RBC Lysing Buffer (Sigma-Aldrich, St. Louis, MO). Monocytes were enriched using the StemCell Technologies monocyte enrichment kit following the manufacturer's protocol (StemCell Technologies). Purity was assessed by flow cytometry at .80% F4/80 + CD11b + . RNA was isolated using the Qiagen RNeasy micro kit (Qiagen), and cDNA was generated for RT-PCR analysis as described above.
FACS analysis
Single-cell suspensions were washed with FACS buffer (PBS/1% FCS) and incubated with combinations of the following Abs: PE anti-mouse F4/80 (clone CI:A3-1; AbD Serotec), PE-Cy7 anti-mouse CD11b (clone M1/ 70; BD Pharmingen), Alexa Fluor 647 anti-mouse Ly6C (clone ER-MP20; AbD Serotec), FITC anti-mouse CD206 (MR5D3; Biolegend, San Diego, CA), allophycocyanin anti-mouse CD11c (clone HL3; BD Pharmingen), FITC anti-mouse programmed death ligand 1 (PDL1) (clone MIH6; AbD Serotec), and goat anti-mouse CCR2 (polyclonal; GeneTex, Irvine, CA) followed by donkey anti-goat FITC (Jackson ImmunoResearch Laboratories, West Grove, PA), and biotinylated anti-mouse TLR2 (clone mT2.7; eBioscience), followed by streptavidin-FITC (BD Pharmingen), allophycocyanin anti-mouse CCR3 (clone 83101; R&D Systems), and PE anti-mouse Siglec F (clone E50-2440; BD Pharmingen). The following Abs were used as appropriate isotype controls: FITC rat IgG2a (clone B39-4; BD Pharmingen), PE rat IgG2a (clone 53-6.7; BD Pharmingen), PE-Cy7 rat IgG2b (clone DTA-1; BD Pharmingen), and Alexa Fluor 647 rat IgG2a (clone R35-95; BD Pharmingen). Cells were analyzed on an FACSCalibur (BD Immunocytometry Systems, San Jose, CA), and analysis was performed using FlowJo software (Tree Star, Ashland, OR).
Generation of BM chimeras
BM was isolated from Nzeg-eGFP (BALB/c) (31) and CCL11 2/2 BALB/c recipients were injected i.v. with 5-10 3 10 6 BM cells/mouse. Engraftment was checked by eGFP + (donor)/eGFP 2 (recipient) cells from the peripheral blood, mesenteric lymph node, and colon by flow cytometry. Seven to 8 wk postirradiation, the mice were administered 5% DSS for 7 d, and colonic eosinophil accumulation was assessed.
Statistical analysis
Data were analyzed by means of ANOVA, followed by the Tukey post hoc test, and correlative analysis was performed using a Spearman rank order correlation coefficient analysis with GraphPad Prism 5 (GraphPad, San Diego, CA). Data are presented as the mean 6 SE. The p values ,0.05 were considered statistically significant.
Results
BM-derived CCL11 is sufficient to reconstitute eosinophil recruitment to the colon of CCL11 2/2 mice during
DSS-induced colitis
We have previously reported a pathological role for eosinophils in DSS-induced colonic injury and that eosinophil recruitment into the colon following DSS treatment was dependent on CCL11 (14) .
With the emerging experimental and clinical data demonstrating an important function for CCL11/eosinophils in IBD, we were interested in defining the cellular source of CCL11 in experimental colitis. To assess if hematopoietic or stromal compartment (SC) expression of CCL11 is sufficient for DSS-induced colonic eosinophilic inflammation, we restricted CCL11 expression to either the BM or SC using BM chimeric mice on the BALB/c background. To restrict CCL11 expression to the BM compartment, we irradiated recipient CCL11 constitution, chimeric mice were exposed to 5% DSS, and eosinophilic inflammation was evaluated. To facilitate analysis of chimerism in BALB/c mice, we transferred BM from BALB/c Nzeg-eGFP mice to WT and CCL11 2/2 BALB/c mice. All cells from the Nzeg-eGFP mice are constitutively GFP positive (31) and can be detected by flow cytometric analysis of autofluorescence. In chimeric mice, eGFP + cells derived from the donor BM are distinguished from any remaining recipient eGFP 2 cells. The degree of chimerism at 7 wk as determined by flow cytometry was 98.2 6 0.2% and 95.4 6 2.1% for peripheral blood monocytes and eosinophils, respectively, and 72.0 6 0.6% for mesenteric lymph nodes (CD4 + T cells) (mean 6 SEM; n = 3 to 4 mice per group) (Supplemental Fig. 1A-C) . Percent reconstitution of colonic MFs at baseline and following DSS was 66.9 6 2.8% and 93.3 6 1.2%, respectively, as determined by flow cytometry (Supplemental Fig. 1D, 1E ). Chimerism was also determined for baseline colonic CD4 + T cells, B cells, and eosinophils (Supplemental Fig. 1D, 1E ). Following the verification of reconstitution, mice were exposed to DSS for 7 d, and colonic eosinophil inflammation was quantitated. the colon of mice following 7 d of exposure to 2.5% DSS (14) . We therefore assessed the relationship between myeloid cell and DSS-induced eosinophilic inflammation. First, we performed flow cytometry analysis on peripheral blood monocytes and colonic MFs at baseline and following DSS exposure ( Fig. 2A) (Fig. 2B) . In conjunction, the CX 3 CR1 low cells within the colon of DSS-treated mice were found to be F4/80 + CD11b + Ly6C high , consistent with the infiltrating monocyte population (Fig. 3A) .
Following our confirmation that CX 3 CR1 and Ly6C expression could distinguish between the two intestinal myeloid subpopulations, we purified CX 3 CR1 low Ly6C
high cells from the colons of CX 3 CR1
eGFP/+ mice following DSS exposure using flow sorting (Fig. 3B) . Purity of CX 3 CR1 low Ly6C
high cells was .95% as assessed by flow cytometry (data not shown). For compara- tive analyses, we also purified blood CX 3 CR1 low F4/80 + CD11b + Ly6C high monocytes from CX 3 CR1 eGFP/+ mice at baseline and on day 5 of DSS ( Fig. 4A, 4B ). PCR analyses revealed no detectable Ccl11 mRNA expression in CX 3 CR1 low Ly6C
high peripheral blood monocytes at baseline or following DSS (Fig. 3C ). Ccl11 mRNA expression was induced in the colonic CX 3 CR1 low Ly6C high cells following infiltration into the colon during DSS-induced colitis (Fig. 3C) MFs had a similar phenotype to the peripheral blood population, as they were positive for Chi3l3, Trem1, Cxcl10, Tnfa, and Pdgfb mRNA transcripts with no detectable Ccl17 expression (Fig. 3C and data not shown) . Interestingly, DSS exposure did not significantly influence the Ly6C high peripheral blood population, as we observed no significant difference in the gene profile between control and DSS-treated Ly6C high peripheral blood cells (Fig. 3C) . However, we detected increased mRNA transcripts for Arg1, Il10, Ccl4, Il1b, Il6, Cxcl2, Retnla, and Ccl22 in the Ly6C high colonic population compared with the Ly6C high peripheral blood population (Fig. 3C) high colonic monocyte/MF flow sorted on day 5 of DSS. C, cDNA was made, and gene expression of Ccl11, Il1b, Tnf, Il6, Ccl4, Cxcl2, Arg1, Il10, Retnla, and Ccl22 was analyzed by RT-PCR. Three to four mice were pooled per sample. Peripheral blood baseline (6 samples), peripheral blood day 5 DSS (3 samples), and colon day 5 DSS (7-10 samples) monocyte/MF expression was analyzed. Data represent the mean 6 SEM. Significant differences (*p , 0.05, **p , 0.01) between groups. ND, below limit of detection. (Fig. 5A , 5B (Fig. 5C, 5D ). Immunofluorescence analyses of F4/80 + cells in the colonic lamina propria of DSS-treated WT mice and CCR2 2/2 mice revealed a loss of the large F4/80 + infiltrate in the CCR2 2/2 mice (Fig. 5E ). This reduction was specific for Ly6C high monocytes, as recruitment of F4/80 2 CD11b + cells (neutrophils) was not impaired (Fig. 5F, 5G ). The reduction in intestinal MF levels was not due to decreased levels of homeostatic intestinal MFs, as the levels of resident F4/80 + CD11b + Ly6C low colonic MFs were comparable between WT and CCR2 2/2 mice (Fig. 5H,   5I ). Collectively, these data indicate that homeostatic resident F4/80 + CD11b + Ly6C low colonic MF levels are independent of CCR2, whereas F4/80 + CD11b + Ly6C high monocyte recruitment to the colon during DSS-induced colitis is CCR2 dependent.
DSS-induced colonic inflammation and colitis is attenuated in CCR2
2/2 mice
To assess the contribution of F4/80 + CD11b + Ly6C high monocytes to DSS-induced colonic CCL11 expression and eosinophilia, we quantitated CCL11 and eosinophil levels in the colon of CCR2 2/2 mice following DSS exposure. Importantly, colonic eosinophil levels and distribution at baseline were comparable between WT and CCR2 2/2 mice, indicating no role for CCR2 in basal colonic eosinophil recruitment (Fig. 6A, 6B and data not shown). DSS treatment of WT mice induced a significant increase in colonic eosinophil levels (Fig. 6A, 6B ). In contrast, there was no significant increase in eosinophil levels in DSS-treated CCR2 2/2 mice (Fig. 6A, 6B) . Notably, the reduction in colonic eosinophil levels was associated with no significant increase in colonic CCL11 levels in colonic punch biopsies from DSS-treated CCR2 high monocytes to the colon by CCR2 deficiency was associated with decreased production of proinflammatory cytokines IL-6 and TNF-a (Fig.  7D) . Collectively, these studies identify that Ly6C high colonic monocytes/MFs have a pathogenic role in DSS-induced proinflammatory cytokine production and histopathology and that recruitment of this cell population is mediated by CCR2-dependent pathways.
CCL2 is a CC chemokine that binds to the CCR2 receptor, and experimental data indicate that this chemokine is important in the recruitment of monocytes and MFs into inflamed tissues (37) (38) (39) . Notably, DSS exposure induced a significant increase in colonic CCL2 protein levels (Supplemental Fig. 4A ). To evaluate the relative contribution of CCL2 to DSS-induced Ly6C high monocyte recruitment into the colon and disease pathology, we examined CCL2 2/2 mice. Surprisingly, the levels of colonic F4/80 + CD11b + Ly6C high monocytes in the colon of DSS-treated CCL2 2/2 mice were comparable to that of strain-and weight-matched DSStreated WT mice (Supplemental Fig. 4B, 4C ). Consistent with our data, recruitment of F4/80 + CD11b + Ly6C high monocytes into the colon of CCL2 2/2 mice was associated with DSS-induced weight loss and disease activity (Supplemental Fig. 4D ), disease pathology (Supplemental Fig. 4E, 4F) , and colonic eosinophil inflammation (Supplemental Fig. 4G, 4H (Supplemental Fig. 5) .
Discussion
In the current study, we have investigated the molecular regulation of CCL11 and colonic eosinophilic inflammation in an experimental mouse model of DSS-induced colitis. We demonstrate that reconstitution of CCL11 
CD11b
+ Ly6C low population (Supplemental Fig. 2) . The presence of an F4/80 + CD11b + Ly6C low CD11c + dendritic cell population may have contributed to the gene expression heterogeneity seen within this cell population. The F4/80 + CD11b + Ly6C high monocytes are an inflammatory monocyte population and rapidly recruited into tissues following inflammatory insult. Large infiltrates of Ly6C high CX 3 CR1 low CCR2 + blood monocytes have been observed in the peritoneum and injured myocardium following immune stimulation (35, 40) . Similarly, we observed the selective increase in the numbers of F4/80 + CD11b + Ly6C high cells within the colon following DSS exposure. Importantly, the F4/80 + CD11b + Ly6C high cells within the colon were CD11c 2 , indicating that this population did not contain a contaminating dendritic cell population (Supplemental Fig. 2) . Consistent with previous investigations, we show that the recruitment of the inflammatory F4/80 + CD11b + Ly6C high monocytes/MFs into inflamed tissues high monocytes/MFs into the colon was not dependent on CCL2. CCR2 is a promiscuous chemokine receptor binding multiple ligands, including CCL2, CCL8, CCL7, and CCL13 (42) . Additionally, CCL2, CCL8, and CCL7 have been shown to be increased in the colon in inflamed tissue from IBD patients as well as in the DSS model of colitis (43, 44 high cell population is consistent with the previously reported DSS-induced total increase in tissue ARG1 and YM1 protein (46) . The expression of Arg1 and Chi3l3 (YM1) suggests that the monocytes/MFs are alternatively activated; however, we also observed evidence of classical activation as the cells expressed the proinflammatory cytokines/chemokines Il1b, Il6, Ccl4, and Cxcl2. Surprisingly, Tnfa mRNA expression was not increased in Ly6C high colonic monocytes compared with peripheral blood monocytes, although protein expression correlated with Ly6C high monocyte recruitment. However, it has previously been shown that Tnf mRNA stability and translation regulate its bioreactivity (47) (48) (49) (50) . Our results suggest that Ly6C high colonic monocytes/MFs have a mixed classically/alternatively activated phenotype in the acute phase of DSS-induced colitis, further indicating that classical/alternatively activated phenotypes are part of a spectrum of activation as opposed to the strongly polarized phenotypes that are often seen in vitro (51, 52) . Alternatively, the mixed phenotype could suggest the presence of subpopulations of Ly6C high colonic monocytes/MFs within the colon. DSS-induced colitis has been linked with increased expression of the classical/ alternative activation cytokines IL-4/IFN-g (53, 54) . In a mouse model of kidney injury, Chi3l3 was expressed in Ly6C + MFs in the kidney; however, other M2 genes, including Ccl17 and Ccl22, were only expressed at very low levels, whereas high levels of Cxcl2 and Il1b were expressed, indicating an M1-biased pattern (55) . Further investigations are required to determine whether the Ly6C high monocyte/MF population consists of multiple polarized monocyte/MF subsets of different phenotypes or whether the Ly6C high monocyte/MF population is simply plastic and adapts to exogenous and endogenous stimuli within the microenvironment.
The role of monocytes/MFs in eosinophil recruitment during chronic inflammatory responses and the relative contribution of CCL11 to this response are not yet fully delineated. Previous studies have demonstrated Ccl11 mRNA expression in MFs in allergen-induced cutaneous biopsies in atopic patients (56) and in bronchial biopsies from asthmatic patients that possess eosinophils (57) . Furthermore, a recent study also demonstrated CCL11 expression in lung MFs from rhinovirus-infected allergic mice with pulmonary eosinophilic inflammation (58) . Experimental analyses employing a Nippostrongylus brasiliensis infestation model have demonstrated a role for monocyte/MF populations in eosinophil recruitment into peritoneum. Similar to our observations, eosinophil recruitment was associated with Retnla and Chi3l3 monocyte/MF expression but was not associated with Ccl11 expression (59) . We show that during colonic inflammation,
high colonic monocytes/MFs are the primary cellular source of CCL11 and that this cell population is sufficient to mediate colonic eosinophilic inflammation. These observations suggest that DSS exposure stimulates CX 3 CR1 + Ly6C high colonic monocyte/MF recruitment in the colon and that the recruited inflammatory monocytes/MFs subsequently drive eosinophil infiltration via a CCL11-dependent pathway. We have previously characterized eosinophil infiltration of the colon following DSS exposure and reported that eosinophil levels begin to increase on day 5 of DSS exposure (14 Fig. 3 ). These kinetic data indicate that F4/80 + CD11b + Ly6C high monocytes/MFs are strategically positioned in the colon to regulate DSS-induced eosinophil recruitment. These studies strongly suggest that CCL11 is predominantly monocyte/MF-derived and is important in colonic eosinophilic recruitment in experimental colitis. We have previously reported a critical role for CCL11 and not the other eotaxin family members CCL24 and CCL26 in the regulation of eosinophilic inflammation in experimental and human IBD (14) . Moreover, eosinophil recruitment into the colon during experimental colitis was attenuated in CCL11 2/2 and not CCL24 2/2 mice, and elevated Ccl11 mRNA levels in lesional biopsy samples from IBD patients positively correlated with eosinophil numbers (14) . Furthermore, we have previously identified CCL11 + CD68 + monocytes/MFs in colonic biopsies of pediatric UC patients. The demonstration of a link between colonic eosinophilic inflammation and DSS-induced histopathology suggests a role for eosinophils in the DSS-induced colonic injury. This is consistent with previous demonstration by us and others of a partial role for eosinophils in DSS-induced epithelial histopathology (14) (15) (16) 33) . Furthermore, this is supported by significant clinical evidence demonstrating increased eosinophils and eosinophil-derived granule proteins in adult UC and CD and a positive correlation between levels of eosinophils and histological score in rectosigmoid colonic biopsy samples from pediatric UC patients (4, 9, 14, 60, 61) . We have previously published that mice deficient in eosinophils (PHIL) are partially protected from DSS-induced colitis (33) . Moreover, we observed a 48% reduction in histological score between DSS-treated WT versus PHIL mice (14) . Notably, in the current study, we observed a 52% reduction in histological score between DSS-treated WT versus CCR2 2/2 mice (histological score WT DSS: 15.7 6 0.8 versus PHIL DSS: 7.7 6 0.6; n = 9 to 10 per group; mean 6 SEM; p = 0.001; Fig. 7 ). The reduction in histopathology in CCR2 2/2 mice was associated with reduced F4/80 + CD11b + Ly6C high monocyte/MF recruitment and reduced CCL11 expression and eosinophil infiltration. These data suggest that a significant component of monocyte/MF-mediated DSSinduced histopathology is mediated via regulation of eosinophil function.
BM chimera experiments in mice indicate that BM cell-derived CCL11 is sufficient for DSS-induced colonic eosinophilic inflammation. Moreover, CCL11
2/2 mice reconstituted with WT BM restored eosinophil recruitment to the colon during DSSinduced colonic injury. As BM reconstitution is not selective for Ly6C high monocyte-derived CCL11, we cannot rule out the contribution of other BM-derived cell populations; however, we have previously demonstrated that DSS-induced CCL11 expression in the colon was restricted to F4/80 + myeloid cells and not F4/80 2 cells (14) . Surprisingly, we observed a significant eosinophilic infiltrate in the colon following DSS exposure in WT mice reconstituted with BM from CCL11 2/2 mice, suggesting a role for structural cell-derived CCL11 in colonic eosinophilic inflammation. We postulate that this paradoxical observation is due to the radioresistance of monocytes/MFs and the effects of radiation on monocyte/MF function. Many studies have demonstrated that tissue MFs are radioresistant (62) (63) (64) . For example, in the lung, it takes .90 d for alveolar MFs to reach ∼80% reconstitution (64) . Similarly, we found that Ly6C low colonic MFs only reached ∼60% reconstitution at ∼50 d postirradiation and that ∼5% of monocytes/MFs in the colon of DSS-treated mice were recipient-derived cells. Furthermore, irradiation has been shown to induce MF oxidative injury (65) as well as alter MF activation, which may lead to homeostatic resident MF involvement in eosinophil recruitment (66) . We currently cannot rule out a contribution for non-BM cell-derived CCL11 to eosinophil recruitment during DSS-induced colitis; however, our previous data demonstrating CCL11 expression restricted to F4/ 80 + cells in the lamina propria of the colon on day 7 of DSS exposure (14) and our observations in CCR2 2/2 mice indicate that the CCR2-dependent Ly6C high monocytes are sufficient to drive eosinophil recruitment in DSS-induced colonic injury.
Recently, a number of unique loci were identified to be associated with early-onset IBD susceptibility including the C-C motif chemokine cluster on 17q12 loci, which contains the eosinophilspecific chemokine gene CCL11 (17) . Clinical and experimental data indicate: 1) a strong relationship between eosinophils and the exacerbation and severity to IBD; and 2) a pivotal role for MFs in the augmentation of the intestinal inflammatory response associated with IBD (67). We provide evidence of a direct pathway involving Ly6C high colonic monocyte/MF-derived CCL11 in colonic eosinophilic inflammation and histopathology in experimental colitis. These studies provide significant rationale for the assessment of monocyte/MF-derived CCL11 in human IBD and the targeting of the monocyte/MF/CCL11 pathway as a therapeutic modality for the treatment and prevention of IBD.
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